These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26694988)

  • 1. Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis.
    Brar K; Leung DY
    Expert Opin Biol Ther; 2016; 16(4):507-14. PubMed ID: 26694988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for managing elderly patients with atopic dermatitis.
    Napolitano M; Potestio L; Nocerino M; Patruno C
    Expert Rev Clin Immunol; 2024 May; 20(5):501-511. PubMed ID: 38193289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reunderstanding of atopic dermatitis in the elderly].
    Song ZQ; Deng SS
    Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(32):2470-2474. PubMed ID: 37650193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atopic Dermatitis Disease Complications.
    Ashbaugh AG; Kwatra SG
    Adv Exp Med Biol; 2024; 1447():59-67. PubMed ID: 38724784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ-inducible protein 10 augments atopic dermatitis via amplifying Th2 immune response.
    Choi YA; Kim N; Jeong NH; Kwon TK; Bang JS; Jang YH; Kim SH
    Allergy; 2024 Jan; 79(1):235-238. PubMed ID: 37548260
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarkers for phenotype-endotype relationship in atopic dermatitis: a critical review.
    Park CO; Kim SM; Lee KH; Bieber T
    EBioMedicine; 2024 May; 103():105121. PubMed ID: 38614010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Allergic Reactions on Food-Specific IgE Concentrations and Skin Test Results.
    Sicherer SH; Wood RA; Vickery BP; Perry TT; Jones SM; Leung DY; Blackwell B; Dawson P; Burks AW; Lindblad R; Sampson HA
    J Allergy Clin Immunol Pract; 2016; 4(2):239-45.e4. PubMed ID: 26718150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of topical phosphodiesterase 4 inhibitor E6005 on Japanese children with atopic dermatitis: Results from a randomized, vehicle-controlled exploratory trial.
    Nemoto O; Hayashi N; Kitahara Y; Furue M; Hojo S; Nomoto M; Shima S;
    J Dermatol; 2016 Aug; 43(8):881-7. PubMed ID: 26703371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of concomitant topical therapy in moderate-to-severe atopic dermatitis treated with cyclosporine.
    Kim JE; Shin JM; Ko JY; Ro YS
    Dermatol Ther; 2016; 29(2):120-5. PubMed ID: 26799345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis.
    van der Schaft J; Politiek K; van den Reek JM; Kievit W; de Jong EM; Bruijnzeel-Koomen CA; Schuttelaar ML; de Bruin-Weller MS
    Br J Dermatol; 2016 Jul; 175(1):199-202. PubMed ID: 26785104
    [No Abstract]   [Full Text] [Related]  

  • 11. TSLP polymorphisms, allergen exposures, and the risk of atopic disorders in children.
    Wang IJ; Wu LS; Lockett GA; Karmaus WJ
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):139-45.e1. PubMed ID: 26712523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus.
    Tavakolpour S
    Dermatol Ther; 2016 Sep; 29(5):299. PubMed ID: 26800435
    [No Abstract]   [Full Text] [Related]  

  • 13. Atopic dermatitis phenotype with early onset and high serum IL-13 is linked to the new development of bronchial hyperresponsiveness in school children.
    Lee E; Lee SH; Kwon JW; Kim YH; Cho HJ; Yang SI; Jung YH; Kim HY; Seo JH; Kim BJ; Kim HB; Lee SY; Kwon HJ; Hong SJ
    Allergy; 2016 May; 71(5):692-700. PubMed ID: 26797819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How the innate immune system trains immunity: lessons from studying atopic dermatitis and cutaneous bacteria.
    Skabytska Y; Kaesler S; Volz T; Biedermann T
    J Dtsch Dermatol Ges; 2016 Feb; 14(2):153-6. PubMed ID: 26788792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic Profile, Safety, and Tolerability of Crisaborole Topical Ointment, 2% in Adolescents with Atopic Dermatitis: An Open-Label Phase 2a Study.
    Tom WL; Van Syoc M; Chanda S; Zane LT
    Pediatr Dermatol; 2016; 33(2):150-9. PubMed ID: 26777394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults.
    Simpson EL; Bieber T; Eckert L; Wu R; Ardeleanu M; Graham NM; Pirozzi G; Mastey V
    J Am Acad Dermatol; 2016 Mar; 74(3):491-8. PubMed ID: 26777100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of primary and secondary prevention in atopic dermatitis.
    Oszukowska M; Michalak I; Gutfreund K; Bienias W; Matych M; Szewczyk A; Kaszuba A
    Postepy Dermatol Alergol; 2015 Dec; 32(6):409-20. PubMed ID: 26755903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaboration in best practices for care of patients with atopic dermatitis.
    Meadows S; Fending D; Boguniewicz M
    J Allergy Clin Immunol Pract; 2016; 4(2):347-9.e1. PubMed ID: 26755101
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and immunological responses of dust mite sensitive, atopic dogs to treatment with sublingual immunotherapy (SLIT).
    DeBoer DJ; Verbrugge M; Morris M
    Vet Dermatol; 2016 Apr; 27(2):82-7e23. PubMed ID: 26749020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 25-hydroxyvitamin D3 levels in children with allergic or nonallergic rhinitis.
    Dogru M; Suleyman A
    Int J Pediatr Otorhinolaryngol; 2016 Jan; 80():39-42. PubMed ID: 26746610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.